SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
ETFs
Ratings
ENZON PHARMACEUTICALS
(NQNM:ENZN Last Sale: 1.74 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NQNM: (ENZN : $1.74)
$79 million Market Cap at September 12, 2013
Employs 300.
Biomedics SubIndustry up .00% / Health Industry up .00% Today

685 Route 202/206 Research Report Earnings Snapshot - Last 03/18/17
Bridgewater, NJ 08807 Fact Sheet
Phone: (908) 541-8600 Financial Statements
Peer Comparison
Annual Reports

Jeffrey H. Buchalter, Chmn./Pres./CEO, Craig Tooman, CFO
Develops advanced therapeutics for life-threatening diseases through the application of its proprietary drug delivery and targeting technologies. On October 29, 2004, announced that would restate financial statements for the year ended June 30, 2004.
Historical Charts    Technical Analysis
No Historical Data available for ENZN

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common ENZN $1.74 $ 0 $1.72 $1.83 128,065 $1.54 $7.47 45,298
Capitalization
Earnings Summary ()
*** No Earnings Available***
-10121
Common Stock $78,819

A460
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2024 Stock Smart with all rights reserved
Feed is currently being brought back up
Provided by Nanex